PATENT CLAIM ANALYSIS

Application Number: 15958308
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "489000"]

Abstract:
An improved manufacturing process produces microcrystalline hydroxyapatite with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.

Claim (Index 17):
The high osteocalcin microcrystalline hydroxyapatite preparation according to  claim 9 , comprising at least 10 \u03bcg/g osteocalcin.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.34
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14916695', '11855807', '10241616', '11746832', '12188127']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6761286732545677
- 35 USC 102 Novelty (BERT): 0.5448478358886014
- Combined Prediction Score: 0.663000589517971
- Mean Citation Score: 203.472294
- Max Citation Score: 409.71204
- Similarity Product: 276.6692615901804

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test